3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
12
Ovarian Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Glioblastoma
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
pembrolizumab
3
Radiotherapy
3
Radiation
3
Biopsy
3
pazopanib
2
palbociclib
2
abemaciclib
2
Immunoglobulin G
2
Ifosfamide
2
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
mirdametinib
1
liposomal doxorubicin
1
eribulin
1
durvalumab
1
cemiplimab
1
X-Rays
1
Vincristine
1
Temozolomide
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Disulfides
×
90 days
×
Clear all
NCT04668300
2026-04-15
DOSa
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
75 enrolled